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Abstract
Background: Hospitals are frequently faced with high levels of emergency department presentations and demand
for inpatient care. An important contributing factor is the subset of patients with complex chronic diseases who
have frequent and preventable exacerbations of their chronic diseases. Evidence suggests that some of these hospital
readmissions can be prevented with appropriate transitional care. Whilst there is a growing body of evidence for
transitional care processes in urban, non-indigenous settings, there is a paucity of information regarding rural and
remote settings and, specifically, the indigenous context.
Methods: This randomised control trial compares a tailored, multidimensional transitional care package to usual care.
The objective is to evaluate the efficacy of the transitional care package for Indigenous and non-Indigenous Australian
patients with chronic diseases at risk of recurrent readmission with the aim of reducing readmission rates and
improving transition to primary care in a remote setting. Patients will be recruited from medical and surgical
admissions to Alice Springs Hospital and will be followed for 12 months. The primary outcome measure will be
number of admissions to hospital with secondary outcomes including number of emergency department
presentations, number of ICU admissions, days alive and out of hospital, time to primary care review post discharge
and cost-effectiveness.
Discussion: Successful transition from hospital to home is important for patients with complex chronic diseases.
Evidence suggests that a coordinated transitional care plan can result in a reduction in length of hospital stay
and readmission rates for adults with complex medical needs. This will be the first study to evaluate a tailored
multidimensional transitional care intervention to prevent readmission in Indigenous and non-Indigenous
Australian residents of remote Australia who are frequently admitted to hospital. If demonstrated to be effective
it will have implications for the care and management of Indigenous Australians throughout regional and remote
Australia and in other remote, culturally and linguistically diverse populations and settings.
Trial registration: Australian New Zealand Clinical Trials Registry, ACTRN12615000808549- Retrospectively
registered on 4/8/15.
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Background
The impact of frequent hospital attendance on patients
and hospitals
Hospitals are frequently faced with high levels of emer-
gency department presentations and demand for in-
patient care. These demands often exceed the available
resources especially in regional and remote areas where
alternate hospitals or services are distant and difficult to
access. Delayed emergency department review, admitted
patients waiting in emergency departments and long
hospital elective waiting lists can, in part, be traced back
to a lack of inpatient beds [1–4]. An important contrib-
uting factor to this mismatch between the demand for
inpatient care and its availability is the admission of an
often small but important sub-set of patients who have
frequent and preventable exacerbations of their chronic
diseases [5]. This is often compounded by a lack of, or
limited access to, community-based social and primary
health care supports. Such hospital admissions remove
an individual from their family and community supports,
limit their ability to undertake usual activities and ex-
pose them to risk of infection and other nosocomial
complications. Many of these are patients with chronic
and other diseases that can, with appropriate community-
based management and support, avoid de-compensation
and the need for inpatient care [6–8].
Recurrent readmissions also pose a financial burden
on a health system that is faced with escalating costs. In
the US, nearly half of the total health care budget is
spent on inpatient services. Existing studies have dem-
onstrated that readmissions account for one quarter of
total inpatient expenditure [9, 10]. Given its impact on
total health care expenditure cost containment associ-
ated with acute inpatient care is an important focus [11].
This has encouraged the development of initiatives that
aim to decrease length of inpatient stay, increase the use
of day procedures, transfer care to the community set-
ting including “hospital in the home” programs and re-
duce preventable hospital readmission [10, 12]. Evidence
indicates that even a small reduction in readmission
numbers could have a substantial financial benefit.
Preventing repeated attendance and readmission to
hospital
Existing literature suggests many hospital readmissions
are related to preventable or avoidable causes [13]. Tar-
gets for initiatives that might reduce readmission include
improved patient and family education and community-
based support, pre-discharge planning and community
and primary health care based liaison, early follow-up
and ongoing chronic disease management. Despite many
health care services allocating significant resources to
facilitating hospital discharge and preventing readmis-
sion evidence supporting a particular approach is limited
and largely lacking for disadvantaged, remote and Indi-
genous Australian populations.
One hospital-based readmission prevention initiative
is discharge planning. This involves the development of
an individualised plan for a patient prior to leaving hos-
pital. The aim is to reduce length of hospital stay and
unplanned readmission, and improve the coordination
of hospital and community-based services following
discharge [14]. Evidence suggests that a coordinated
discharge plan tailored to the individual patient brings
about a reduction in length of hospital stay and re-
admission rates for adults with complex medical needs.
Specific interventions include formal assessment for
risk factors relating to delayed and failed discharge, patient
education, medication reconciliation, discharge care plans
and post discharge follow-up including telephonic review,
home visits and timely review with a primary care pro-
vider. Dedicated discharge planning staff to coordinate
this process has been highlighted as an important con-
tributor to the success of such programs [15, 16].
Many hospitals are already making a significant invest-
ment in attempting to reduce inpatient stays and re-
admission in the form of designated discharge planning
positions and allied health, pharmacy, drug and alcohol,
social work, mental health, aged, rehabilitation and pal-
liative care services. While such services are variably
available and accessed by all Australians, the need is
even greater for remote residents, who already face limi-
ted access to health care, and Indigenous Australian pa-
tients who are more likely to face issues relating to a
greater burden of co-morbidity, language, intercultural
communication, remoteness and economic and environ-
mental disadvantage.
Alice Springs Hospital and frequent hospital admissions
Alice Springs Hospital is the regional referral centre for
Central Australia. It has a catchment of approximately
50,000 residents incorporating Alice Springs and up to 50
remote communities that range between 80 and 1000 kms
from the hospital. Indigenous Australians, who are often
faced with significant and complex health needs, represent
40% of this population. A combination of a remote popu-
lation with a high burden of complex and chronic disease
can result in high levels of emergency patient presenta-
tions to Alice Springs Hospital and delays in transfer to in-
patient wards which can in turn rapidly lead to an
overcrowded emergency department, increased waiting
times and, by extension, poorer patient outcomes [3]. As
previously noted, an important potential factor contribut-
ing to this issue are patients who repeatedly attend hos-
pital and require admission due to a combination of
preventable exacerbations of their chronic disease and a
lack of community-based support.
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A particular group at risk of re-admission to Alice
Springs Hospital are adult patients with, usually mul-
tiple, chronic but not immediately life threatening dis-
eases such as chronic lung (Chronic Obstructive
Pulmonary Disease (COPD)/bronchiectasis/asthma) and
heart (heart failure, coronary artery disease) disease [17,
18]. In Alice Springs, many of these patients are Aborigi-
nal people who may live in Alice Springs or remote
communities up to 1000km distant from the hospital. In
2012, excluding oncology and renal dialysis patients,
there were more than 320 adult medical patients (90%
Aboriginal Australian) admitted to Alice Springs Hospital
who had more than five admissions over the preceding
year. These patients had an average of eight admissions per
year and accounted for over 2500 admissions or approxi-
mately 25% of adult medical admissions. Thus, 320 adult
medical patients or less than 1% of the adult population of
Central Australia, accounted for one quarter of the admis-
sions to the adult medical service at Alice Springs Hospital.
There is currently no consistent definition for unplanned
hospital readmissions. This makes comparison of data diffi-
cult and as a result readmission data is not part of current
hospital performance frameworks. Australian data indicate
that across all hospitals (public and private) and age groups,
1% of patients are readmitted within 28-days [19]. A recent
study at Flinders Medical Centre in South Australia found
that just over 10% of patients were being readmitted within
28 days of discharge. Those patients with respiratory,
neurological or genitourinary and trauma were more likely
to be readmitted. Risk factors for readmission included
increased length of stay, high co-morbidity index scores
and discharge against medical advice [19].
Much of the current research relating to miminising
hospital stay and readmission has been conducted with
specific medical populations including heart failure or
COPD [20–25]. Recent data from three randomised trials
indicated that multidisciplinary home-based case manage-
ment for patients hospitalised with the full spectrum of
chronic heart disease are effective in prolonging days alive
and out of hospital and avoiding recurrent hospitalisation
[26]. Whilst some research has been conducted in vulner-
able populations, including low socioeconomic or ethnic
minority groups [27–29], such studies do not specifically
address the unique aspects of discharge planning when
dealing with vulnerable, remote populations with a high
burden of disease. There are few specific Australian stud-
ies especially those dealing with a rural/remote context.
Given the lack of evidence, we aim to extend and
adapt the principles of what are often disease-specific,
non-Indigenous and urban based models of readmission
prevention and to evaluate such a more generic model
linking hospitals with primary health care and other
community-based resources in a remote setting with a
large Aboriginal Australian population. To achieve this
we aim to evaluate the efficacy of a tailored multi-
dimensional case-based intervention for people with fre-
quent admissions to the adult specialist medical and
surgical service of a remote Australian hospital with a
particular focus on the needs of Aboriginal people.
Hypothesis
Relative to standard management, a targeted case manage-
ment and discharge planning process aimed at adult med-
ical and surgical inpatients with a history of a) four or
more admissions over the last 12 months or b) more than
seven admissions over the previous 24 months will be ef-
fective in reducing the rate of all-cause rehospitalisation
(primary endpoint) and health care utilisation in the 12
months following the index admission.
Methods/Design
Objectives
The primary objective of this study is to compare a tai-
lored discharge planning and case management ap-
proach for patients who are frequently admitted to Alice
Springs Hospital with patients receiving usual care using
the primary outcome of decreased readmissions. To do
this we will:
i. Develop and evaluate a multidimensional discharge
planning and case-management approach aimed at
reducing all-cause readmissions
ii. Identify factors which predict readmission and
subsequent mortality and thus factors which identify
patients who are most likely to benefit from this
intervention
iii. Evaluate the efficacy and cost-effectiveness of this
tailored case management-based approach
Study design
In this randomised control trial conducted according to
CONSORT guidelines for a pragmatic trial of a health
service intervention, participants will be randomly allo-
cated to either of two study arms using a concealed al-
location procedure [30]. The study arms will include an
intervention group who will participate in the case
management approach over 12 months and a control
group who will receive usual hospital-based care including
discharge planning using the existing hospital-based,
nurse led service. The case management approach will
be delivered by a team consisting of a medical officer,
Aboriginal Health Practitioner, nurse and pharmacist.
Figure 1 summarises a patient’s journey through the
study protocol.
Data collection will occur at enrolment, at each subse-
quent admission to hospital and at the conclusion of the
study when primary health care utilisation and survival
data will be collected. The primary outcome of interest
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will be a reduction in the number of admissions to hos-
pital over the 12 month period following enrolment and
will be based on intention to treat.
Study setting
This study will be conducted at Alice Springs Hospital,
the regional referral centre for remote Central Australia
with 186 inpatient beds. It is the major teaching hospital
servicing approximately 50,000 residents of both Alice
Springs and up to 50 remote communities that range
between 80 and 1000kms from the hospital (See Fig. 2).
The nearest tertiary hospital referral centres, Darwin and
Adelaide, are approximately 1500 km away by road.
Study population
Subjects will be identified within 48 h of admission
under an adult, general medical or surgical team.
Alice Springs Hospital does not have sub-specialty
adult medical units (e.g. cardiology, gastroenterology
etc.) but each of the three adult general medical units
tend to focus on one or more medical sub-specialties.
Surgical patients will be required to have one or more
pre-existing chronic disease diagnoses which have
contributed to the current admission (e.g. foot ulcer
with diabetes). Whilst enrolment will not be restricted
to Indigenous Australians the majority of people re-
quiring frequent admission to Alice Springs Hospital
are Aboriginal Australians.
Fig. 1 Patient flow through study protocol
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Inclusion criteria
1. 18 years and older
2. 4 or more adult medical and/or non-elective surgical
admissions over the preceding 12 months or 8 over
the preceding 24 months
a. Surgical admissions will be counted if
deemed a consequence of a chronic disease
such as diabetic foot infections, acute/chronic
pancreatitis and cellulitis
3. Resident of Central Australia (including the
cross border regions of Western Australia and
South Australia and extending north to Elliot in
the Northern Territory).
Exclusion criteria
1. Anticipated life expectancy of 12 months or less
based on treating specialist assessment
Fig. 2 Map of catchment area for Alice Springs Hospital
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2. Stage 5 chronic kidney disease (eGFR < 15ml/min or
receiving renal replacement therapy)
3. Solid organ transplant (including renal transplant)
4. Active palliative care involvement
5. Previously been enrolled in the study (such subjects
will have on-going care as per their original study
allocation)
Randomisation: allocation, concealment and sequence
generation
A computerised randomisation database using Micro-
soft Access will be utilised. Given the resource implica-
tions of the intervention, the randomisation ratio will
be unequal with one participant allocated to the inter-
vention group for every two allocated to the control
group. Block randomisation will be used to randomly
assign participants to intervention or usual care with
participants being randomised in blocks of 21. Each
block will have seven participants randomly assigned to
the intervention and 14 participants to the control arm.
Once eligibility is confirmed and the participant con-
sented, the local study team will enter the enrolled par-
ticipant’s details into the database and allocation will be
automatically assigned.
Whilst allocation will be concealed the nature of the
intervention will mean participants, research team mem-
ber and local health care staff are aware of which group
each participant has been allocated to. Staff assessing
primary endpoint data and those involved with the ana-
lysis will be blinded to the study allocation.
Intervention
Participants will be informed that they will be randomly
assigned to a group that receives ‘usual care’ or a group
that receives extra support in the form of a transitional
care package.
Participants assigned to the control group
Participants allocated to the control group will receive
usual care in the form of existing discharge planning ser-
vices provided by Alice Springs Hospital. This includes a
varying combination of patient education regarding
their health conditions and referral to allied health ser-
vices (e.g. physiotherapy, occupational therapy, dieti-
cian, speech pathology, social work, substance abuse
and addiction, and pharmacy services).
Participants assigned to intervention group
Participants allocated to the intervention group will re-
ceive the usual services as described above. In addition
they will be provided with a multi-dimensional and case-
based transitional care package led by a designated team
consisting of a medical officer, nurse, Aboriginal Health
Practitioner and pharmacist. At each admission, the
participants will have the following provided during their
inpatient stay. This is also summarised in Fig. 3:
1. A comprehensive needs based semi-structured
interview (including health, social and other
potential drivers of readmission)
2. Coordination of referrals to allied health, social
work, mental health and/or substance abuse and
addiction services based on this needs based
assessment
3. Nurse and medical officer-led education to
participant and family regarding diagnosis and
principles of management supported by Aboriginal
language interpreters and Aboriginal Health
Practitioners
4. Full medication review, reconciliation and bedside
education by the dedicated team pharmacist
5. Case conferencing with ward-based medical and
nursing staff to develop a clear ongoing management
plan including expectations regarding post-hospital
management
6. Liaison with local primary healthcare providers
(including negotiation regarding follow-up and
ensuring high quality, informative discharge
summaries are completed in a timely manner)
7. Development of a written discharge plan with the
treating medical team, participant, primary health
care provider and family with a copy being given to
the participant and sent to a designated individual at
the primary health care site (preferably by email) at
the time of discharge
The intervention team will facilitate the following
activities following discharge through liaison with the
participant, family and/or primary health care provider:
1. Telephone case conference with patient and
family between day 3 and 5 of discharge.
Telephone contact was chosen over home visits
given the potential remoteness of our patient
population and the inherent difficulties in
providing a home based service post discharge.
This semi structured interview with focus on
how the patient is coping post discharge,
any complications/new problems, medication
supply, adherence and side effects, a reminder of
upcoming reviews and any potential barriers
to attending these appointments. The researcher
will provide advice and modify the management
plan depending on outcomes of this phone
interview.
2. Telephone case conference with primary care
provider between day 1 and 5 post discharge.
The researcher will provide the primary care
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provider with a summary of the admission
and discharge plan and an opportunity to
clarify any confusion. The researcher will
also check that the primary care provider
received the written discharge plan and
that the patient has a review appointment
booked.
3. Participant primary health care review within
7 days following hospital discharge.
4. Support for participants if they return to hospital
for outpatient review and/or investigations to
encourage ambulatory service attendance and to
consolidate understanding of management plans
and expectations.
Baseline assessment
Baseline assessment will be undertaken in all partici-
pants who meet eligibility criteria and who consent to be
involved in the study.
Baseline data
i. Allocation (control or intervention)
ii. Demographics (including ethnicity)
iii. Drivers for readmission based on outcomes of a
semi-structured interview at admission
iv. Smoking and alcohol consumption
v. Co-morbidities (clinician diagnosed coronary heart
disease, heart failure, rheumatic heart disease,
Fig. 3 The intervention process
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diabetes mellitus, COPD/bronchiectasis, sleep
related disorders (including obstructive sleep
apnoea), and musculoskeletal disorders
(type and areas/joints affected).
vi. Assessment of premorbid function status using the
Resource Utilization Groups–Activities of Daily
Living (RUG-ADL) [31, 32] and Australian
Modified Karnofsky Performance Scale (AKPS) [33].
vii.Anthropometry and objective physical activity
assessment including:
a. Weight, height and BMI
b. Sit-Rise Test (SRT) and six minute walk test
(6MWT) and as a potential method for
predicting patient survival and an objective,
standardised and reproducible measure of
exercise tolerance respectively [34, 35].
Outcome measures
Determination of endpoints will occur at 12 months
from enrolment and will be based on the CONSORT
Statement [30] including an intention-to-treat analysis.
Determination of endpoints will take account of censuring
relating to participant survival or being lost to follow-up
and will be blinded and subject to secondary panel review
for adjudication where doubt exists regarding interpret-
ation of end point definitions.
Primary endpoint
i. Number of all cause hospital admissions (/months
follow-up) adjusting for survival and loss to follow-up
Secondary endpoints
i. Rate of associated all-cause hospital inpatient days
(/months follow-up)
ii. Overall rate of emergency department attendances
(/months follow-up)
iii. Days alive and out-of-hospital (including linkage
with NT Government Death notifications)
(/months of follow-up) according to actual versus
maximal possible event-free days of survival
iv. Number of ICU/HDU admissions and bed days
(/months of follow-up)
v. Time to first primary health care review following
hospital discharge (days or mean days if more
than one admission)
vi. Health care costs (see Health Economic
Analyses below)
Accuracy of prognostic assessments
Any patient who is excluded based on a clinician deter-
mined expected prognosis less than 12 months will be
followed up 12 months after initial assessment to
determine if they are still alive. This will provide insight
regarding the accuracy of clinician-based prognostic as-
sessments for patients frequently admitted to hospital.
Sample size
Sample size analysis is based on data derived from Alice
Springs Hospital admission data during 2013 regarding
patients suitable for inclusion in this study. Alice Springs
Hospital data indicates more than 300 individual patients
were admitted to Alice Springs hospital over the preceding
12 months who would meet inclusion criteria for this
study. Overall these patients had a mean number of ad-
missions of eight per year (standard deviation four). Based
on an alpha of 0.05 and beta of 0.1 (power of 90%) and a
clinically significant reduction in the number of readmis-
sions of 25% the calculated sample size (control and inter-
vention arms) will be 210 with 70 in the intervention arm
and 140 in the control arm (ratio 1:2) [24].
Recruitment strategies and consent
Participants will be actively recruited through Alice Springs
Hospital over a 24 month period. A list of new admissions
to any of the adult general medical teams will be assessed
daily for patients who meet admission criteria. Twelve
month prognosis will be specifically assessed by asking the
treating specialist physician whether they anticipate a po-
tential participant will be alive in 12 months. If the treating
clinician believes the patient will be alive, or is unsure
whether this is likely, they will be deemed as potentially eli-
gible. Such patients will be assessed against inclusion/exclu-
sion criteria and, if eligible, will be approached by staff to
invite them to take part in the study. We have ethics ap-
proval to follow-up patients deemed to have a prognosis
less than 12 months at the end of the trial with no addi-
tional consent required (HREC-13-159).
The consent process will include explaining the details of
the study with particular reference to the study design, the
possibility participants will be allocated to a control/usual
care group, the nature of the intervention and the confirm-
ation that refusal or later withdrawal will not have implica-
tions for ongoing health care. The participant consent and
information forms can be found in Additional files 1 and 2.
Where appropriate the Aboriginal Health Practitioner
member of the research team will facilitate these discus-
sions to ensure comprehension and cultural security for
Indigenous Australian patients. If necessary local Aboriginal
language translators conversant in Central Australian
languages (including Arrernte, Warlpiri, Yankunytjatjara,
Pitjantjatjara, Luritja, Pintupi-Luritja, Ngaatjatjarra,
Ngaanyatjarra, Alyawarra and Anmatyerre) and local
English idioms will be used if standard English comprehen-
sion is limited [36]. A written English language information
sheet will also be provided and consent to participate con-
firmed with a signed and witnessed consent form.
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Time Schedule (As per SPIRIT Guidelines)
Data management
All information will initially be recorded by the research
team on paper forms. Paper records will be stored under
numerical code in a locked filing cabinet only accessible
to the study personnel. All information collected will be
kept strictly confidential. A member of the research
team will transpose this information into a password
protected Access database on password protected com-
puters. Data entry will be independently checked by a
second member of the research team to ensure accuracy
of data entry. All case files and recorded and entered
data will be randomly assessed by the project manager
to ensure protocol adherence (including that relating to
allocation, randomisation and consent) and that there
are no data omissions or errors in transcription.
Data monitoring
A Data Safety Monitoring Committee (DSMC) has been
created and will be convened in the event of a serious ad-
verse event or protocol deviation. The DSMC will request
documentation from the project team and will assess, in
the case of a serious adverse event, whether this was study
related. The only serious adverse event monitoring
during this study will be death of a participant. Any ser-
ious adverse events will be reviewed by the DSMC and
reported to the supervising ethics committee. Any
protocol deviations or alterations to the study proto-
cols, consent procedures, recruitment process or study
materials require review and approval by the supervis-
ing ethics committee.
An interim analysis will be undertaken after the first
80 participants have been enrolled. This analysis will
focus on incidence density of readmissions and mortality.
These data will be reviewed by the DSMC. A recommen-
dation will be provided to the investigators regarding
whether to continue the trial or, in the case of concerns
regarding harm or clear benefit, whether to prematurely
terminate the study.
Statistical analysis
Statistical analysis of the primary end point will be based
on bivariate analysis for continuous variables for in-
patient days and chi square and survival analysis for all-
cause mortality. Multivariate analysis will be utilised to
develop predictive equations for risk of readmission and
survival utilising baseline data including functional as-
sessment results (Resource Utilization Groups–Activities
of Daily Living (RUG-ADL) [31, 32], Australian Modified
Karnofsky Performance Scale (AKPS) [33] and objective
[6MWT, SRT [34, 35]), measures of function, co-
morbidities (including severity), demographics and an-
thropometry. Analysis will be based on intention to
treat. If data is found to be missing, this item will not be
included which will be associated with deletion of cases
for the prescribed elements.
Health economic analyses
The use of all health care resources will be measured
and multiplied by the respective unit costs. In general,
hospital admissions typically incur higher costs for the
initial period when diagnostic tests and surgical proce-
dures are undertaken. The later days stay are relatively
lower cost with little more than hotel costs incurred.
The use of National Weighted Activity Units will allow
STUDY PERIOD
Enrolment Allocation Post-allocation Close-out
TIMEPOINT** -t1 0 t1 t3 t6 t9 t12 t12
ENROLMENT:
Eligibility screen X
Informed consent X
Allocation X
INTERVENTIONS:
Transitional care program X X X X X
ASSESSMENTS:
≥18yrs, history of ≥4 admissions, prognosis >12mths X
Number of readmissions, Days alive/out of hospital,
ICU bed days, ED presentations, time to GP review post discharge
X
Six minute walk test X X X X X X
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standardisation and categorisation of each readmission
episode into fixed and variable costs [37]. Fixed costs are
those that all surviving patients incur irrespective of
their length of stay, whilst variable costs are a per diem
cost and are dependent on the length of stay. The total
costs will be calculated as the variable costs multiplied
by the length of stay plus the fixed cost. Fixed costs will
include components for the emergency department,
pathology, imaging, allied health professional input,
pharmacy, critical care, prostheses, operating room pro-
cedures and specialist procedure suites. Per diem costs
will include those for medical staff, nursing staff, non-
clinical staff, staff on-costs, supplies, hotel costs (e.g.
meals), and depreciation. Length of stay in intensive care
and critical care units (ICU/CCU), as well overall length
of stay will be ascertained. Accordingly, costs will be cal-
culated using fixed costs plus the mean per diem cost
for ICU/CCU plus the per diem cost for a general ward
multiplied by the lengths of stay in each facility. Costs
for providing the intervention will be calculated based
on time spent by all team members with each patient.
Costs for use of primary care services will be based on
number of visits multiplied by a standard cost for a GP
visit at the time [38].
Ethics
The trial has ethical approval from the Central Australian
Human Research Ethics Committee (HREC-13-159) and
has been registered with the Australian New Zealand
Clinical Trials Registry (ACTRN12615000808549). It is
supported by Alice Springs Hospital and major
community-based stakeholders. The trial will be con-
ducted in compliance with the study protocol, the princi-
ples of good clinical practice [39], the National Statement
on Ethical Conduct in Human Research [40], The
National Health and Medical Research Council’s
Values and Ethics: Guidelines for Ethical Conduct in
Aboriginal and Torres Strait Islander Health Research [41].
Baker IDI indemnifies for the trial and all participants.
Discussion
Emergency waiting times, ambulance ‘ramping’ and hos-
pital waiting lists are all related to a lack of inpatient
hospital beds. Initiatives that reduce hospital admissions
can lessen emergency department overcrowding, im-
prove patient outcomes and leverage additional value
from existing hospital facilities at small cost and without
the need for additional hospital beds. While this applies
to all Australians the need is even greater for Indigenous
Australian patients who face a burden of complex
chronic disease as well as language and cultural barriers
when engaging with the mainstream health system.
Comprehensive discharge planning and transitional care
have been found to be effective in reducing recurrent
admissions to hospital and facilitate re-engagement with
primary care after discharge from hospital. Whether such
findings can be transferred and adapted to a regional and
remote setting with a culturally diverse patient population
that has complex health care needs and is subject to sub-
stantial socioeconomic disadvantage remains to be seen.
This will be the first study to evaluate a tailored multi-
dimensional transitional care intervention to prevent re-
admission in Indigenous and non-Indigenous Australian
residents of remote Australia who are frequently admit-
ted to hospital. If demonstrated to be effective it will
have implications for the care and management of
Indigenous people throughout regional and remote
Australia. It will further be a practical demonstration
and provide valuable insights into how local health care
providers, including community-controlled health orga-
nisations, can provide leadership and coordination of
existing clinical services and facilitate service improve-
ments and health care savings in this setting.
Additional files
Additional file 1: Participant consent form. Trial consent form.
(DOCX 267 kb)
Additional file 2: Participant information form. Trial information form
provided to patients during consenting process. (DOCX 250 kb)
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